Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

If you look at the balance sheet and burn rate you will find the shelf is needed to assure operations beyond mid 2015. The burn rate is going to increase as well. The shelf also offers opportunistic funds...although I am hoping that CTIX stays fixed on K/B/P development.

Taking B through P3 will require part of the shelf and increase value dramatically (given positive results) If there is any doubt about the P3 outcome a partner should be taken on for the platform sooner. Otherwise, it would be good for us if CTIX takes B through at least one P3.

IMO, of course.